More about
Alendronate
News
July 28, 2021
1 min read
Save
Top in endocrinology: Romosozumab vs. alendronate, health effects of shift work
News
July 22, 2021
3 min read
Save
Greater lumbar spine BMD, bone strength gains with romosozumab for postmenopausal women
News
March 29, 2021
2 min read
Save
Denosumab increasingly prescribed in osteoporosis treatment
News
November 12, 2020
3 min read
Save
Denosumab superior to alendronate in raising spinal BMD in long-term glucocorticoid users
News
September 18, 2020
3 min read
Save
Treatment sequence influences romosozumab effectiveness in osteoporosis
News
June 10, 2020
2 min read
Save
Romosozumab reduces vertebral fracture risk in postmenopausal osteoporosis
News
November 13, 2019
3 min read
Save
Great Debate tackles first-line anabolic therapy for glucocorticoid-induced osteoporosis
News
September 30, 2019
3 min read
Save
Bone strength, BMD increase more substantially with romosozumab vs. alendronate

Among a cohort of postmenopausal women randomly assigned to romosozumab or alendronate, larger improvements in bone mineral density and bone strength in the lumbar spine were observed for those taking romosozumab, according to findings presented at the American Society of Bone and Mineral Research annual meeting.
News
September 27, 2019
3 min read
Save